Non-focal prospective memory (PM) is sensitive to age-related decline; an additional impairment in focal PM is characteristic of mild stage Alzheimer’s disease. This research explored whether, by mid-adulthood, the distinct demands of focal and non-focal PM expose differences in carriers of an APOE ε4 allele, a genetic risk factor for Alzheimer’s disease. Thirty-three young and 55 mid-age adults, differentiated by APOE genotype, completed a category-decision task with a concurrent focal or non-focal PM demand. Only mid-age ε4 carriers showed a cost of carrying a focal PM intention. In addition, mid-age ε4 carriers showed a significantly greater cost of carrying a non-focal PM intention than young ε4 carriers, supporting a profile of acceler...
Objective—The knowledge that one carries the apolipoprotein E (APOE) ε4 allele risk factor for Alzhe...
APOE genotype is associated with the risk of Alzheimer’s disease. In the present study, we investiga...
Carriers of the APOE E4 allele have an increased risk of developing Alzheimer's disease. However, it...
Possession of an APOE e4 allele is an established risk factor for Alzheimer’s disease, while the les...
BACKGROUND: Memory problems are a main feature of mild cognitive impairment (MCI) and may be related...
Objectives: The apolipoprotein E (APOE) ε4 allele is an established risk factor for dementia, yet th...
The present study examined whether prospective memory performance discriminates healthy aging from v...
BACKGROUND: The APOE ε4 allele is associated with the risk of late-onset Alzheimer\u27s disease. Th...
We examined whether the apolipoprotein E (APOE) ε4 allele was associated with cognitive benefits in ...
Despite evidence of a relationship between Apolipoprotein E (APOE) ε4+ and later-life cognitive decl...
Increasing age and carrying an APOE ε4 allele are well established risk factors for Alzheimer's dise...
Episodic memory impairment is the hallmark symptom of Alzheimer's Disease (AD). However, episodic me...
Carriers of the APOE e4 allele are at higher risk of age-related cognitive decline and Alzheimer's d...
The human apolipoprotein E (APOE) gene has three alleles (ε2, ε3 and ε4). Relative to the most commo...
The human apolipoprotein E (APOE) gene has three alleles (ε2, ε3 and ε4). Re...
Objective—The knowledge that one carries the apolipoprotein E (APOE) ε4 allele risk factor for Alzhe...
APOE genotype is associated with the risk of Alzheimer’s disease. In the present study, we investiga...
Carriers of the APOE E4 allele have an increased risk of developing Alzheimer's disease. However, it...
Possession of an APOE e4 allele is an established risk factor for Alzheimer’s disease, while the les...
BACKGROUND: Memory problems are a main feature of mild cognitive impairment (MCI) and may be related...
Objectives: The apolipoprotein E (APOE) ε4 allele is an established risk factor for dementia, yet th...
The present study examined whether prospective memory performance discriminates healthy aging from v...
BACKGROUND: The APOE ε4 allele is associated with the risk of late-onset Alzheimer\u27s disease. Th...
We examined whether the apolipoprotein E (APOE) ε4 allele was associated with cognitive benefits in ...
Despite evidence of a relationship between Apolipoprotein E (APOE) ε4+ and later-life cognitive decl...
Increasing age and carrying an APOE ε4 allele are well established risk factors for Alzheimer's dise...
Episodic memory impairment is the hallmark symptom of Alzheimer's Disease (AD). However, episodic me...
Carriers of the APOE e4 allele are at higher risk of age-related cognitive decline and Alzheimer's d...
The human apolipoprotein E (APOE) gene has three alleles (ε2, ε3 and ε4). Relative to the most commo...
The human apolipoprotein E (APOE) gene has three alleles (ε2, ε3 and ε4). Re...
Objective—The knowledge that one carries the apolipoprotein E (APOE) ε4 allele risk factor for Alzhe...
APOE genotype is associated with the risk of Alzheimer’s disease. In the present study, we investiga...
Carriers of the APOE E4 allele have an increased risk of developing Alzheimer's disease. However, it...